Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report-Reference-Cited by-同舟云学术

Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report

Published:2018-06-14 Issue:24 Volume:131 Page:2720-2729
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Holmqvist Anna Sällfors¹²,Chen Yanjun³,Wu Jessica³,Battles Kevin³,Bhatia Ravi⁴,Francisco Liton³,Hageman Lindsey³,Kung Michelle³,Ness Emily³,Parman Mariel³,Salzman Donna⁴,Winther Jeanette Falck⁵⁶,Rosenthal Joseph⁷,Forman Stephen J.⁷,Weisdorf Daniel J.⁸,Arora Mukta⁸,Armenian Saro H.⁷,Bhatia Smita³

Affiliation:

1. Pediatric Oncology and Hematology, Skåne University Hospital, Lund, Sweden;

2. Department of Clinical Sciences, Lund University, Lund, Sweden;

3. Institute for Cancer Outcomes and Survivorship and

4. Division of Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham, Birmingham, AL;

5. Danish Cancer Society Research Center, Copenhagen, Denmark;

6. Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark;

7. Pediatric Hematology/Oncology, City of Hope, Duarte, CA; and

8. Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Abstract

Key Points Two-year survivors of autologous BMT in childhood have a substantially increased risk of late mortality compared with the general population. There has been a significant decline in all-cause mortality in children undergoing autologous BMT over the past 3 decades.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/131/24/2720/1469294/blood831156.pdf

Reference13 articles.

1. A population-based cohort study of late mortality in adult autologous hematopoietic stem cell transplant recipients in Australia;Ashton;Biol Blood Marrow Transplant,2014

2. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study;Bhatia;Blood,2005

3. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation;Martin;J Clin Oncol,2010

4. Late mortality after hematopoietic SCT for a childhood malignancy;Schechter;Bone Marrow Transplant,2013

5. National Death Index. Vol. 2018. https://www.cdc.gov/nchs/ndi/index.htm. Accessed 19 January 2018.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality;Leukemia;2024-04-05

2. Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study;JMIR Research Protocols;2022-07-06

3. Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report;Journal of Clinical Oncology;2022-06-20

4. Living Long and Well After an Autograft;Journal of Clinical Oncology;2022-06-20

5. Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study (Preprint);2022-01-27